Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
Heatwurx, Inc. (to 10/20/2017)
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 615 % -23%
Debt-to-equity 19.7 % +26.7%
Return On Equity -195 % +23.8%
Return On Assets -163 % +26.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.27M shares -86.7%
Common Stock, Shares, Outstanding 3.27M shares -86.7%
Entity Public Float 10.2M USD -69.8%
Common Stock, Value, Issued 327 USD -86.8%
Weighted Average Number of Shares Outstanding, Basic 3.28M shares +143%
Weighted Average Number of Shares Outstanding, Diluted 3.28M shares +143%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 2.04M USD +38.5%
General and Administrative Expense 4.9M USD -31.5%
Operating Income (Loss) -11.8M USD +46.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.01M USD -15.2%
Net Income (Loss) Attributable to Parent -11.5M USD +47%
Earnings Per Share, Basic -4.62 USD/shares +88.5%
Earnings Per Share, Diluted -4.62 USD/shares +33.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.89M USD -57.9%
Assets, Current 4.84M USD -38.8%
Property, Plant and Equipment, Net 5.32K USD +97.4%
Operating Lease, Right-of-Use Asset 146K USD -35.8%
Intangible Assets, Net (Excluding Goodwill) 7.47M USD -9.55%
Other Assets, Noncurrent 173K USD -97.8%
Assets 4.94M USD -38.9%
Accounts Payable, Current 712K USD +106%
Accrued Liabilities, Current 413K USD +104%
Liabilities, Current 1.22M USD +47.6%
Operating Lease, Liability, Noncurrent 21.8K USD -80%
Liabilities 1.22M USD +33.5%
Retained Earnings (Accumulated Deficit) -84.5M USD -15.8%
Stockholders' Equity Attributable to Parent 3.72M USD -48.1%
Liabilities and Equity 4.94M USD -38.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.05M USD +3.08%
Net Cash Provided by (Used in) Financing Activities 6.26M USD -1.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 3.27M shares -86.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.21M USD -0.56%
Deferred Tax Assets, Valuation Allowance 17.6M USD +21.3%
Deferred Tax Assets, Gross 17.6M USD +21.3%
Operating Lease, Liability 88.8K USD -48.2%
Depreciation 139 USD
Lessee, Operating Lease, Liability, to be Paid 93.4K USD -49.9%
Operating Lease, Liability, Current 88.8K USD +7.29%
Lessee, Operating Lease, Liability, to be Paid, Year Two 70K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 70K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.61K USD -69.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 70K USD +4398%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 197K USD +0.73%